Main menu

New approaches for clinical research


Clinical research white paper cover

Overview

The widespread implementation of sequencing technologies over the last decade has delivered unprecedented insight into human health and disease. However, the inherent limitations of legacy short-read sequencing technologies limit their ability to detect many important sources of genomic variation, such as structural variants, repetitive regions, phasing, base modifications, and transcript isoforms.

In this white paper, we explore how nanopore sequencing of native DNA and RNA overcome the limitations of short-read sequencing to deliver the most comprehensive characterisation of the human genome.

In this white paper, you will:

  • Learn the importance of clinical research and its recent developments
  • Discover the limitations of legacy sequencing technologies
  • Find out how nanopore sequencing overcomes these limitations
  • Read real-world case studies of how researchers are utilising nanopore sequencing to deliver new insights that were hidden from view when using legacy sequencing technologies

Download

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag